Rocket Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 11/14/2024 | 17.69 M | $326.69 M | 0.00% | 18.79% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 11.24 M | $207.64 M | 22.79% | 11.94% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.37 M | $117.67 M | 100.00% | 6.77% |
| VANGUARD GROUP INC | 11/13/2024 | 5.54 M | $102.27 M | -4.68% | 5.88% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2024 | 4.49 M | $83.00 M | 3.83% | 4.77% |
| MAVERICK CAPITAL LTD | 11/14/2024 | 4.12 M | $76.07 M | 4.85% | 4.37% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.21 M | $59.25 M | 1.21% | 3.41% |
| STATE STREET CORP | 11/14/2024 | 3.10 M | $57.29 M | 11.59% | 3.29% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2.15 M | $39.68 M | -23.77% | 2.28% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.90 M | $35.06 M | -35.00% | 2.02% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 1.73 M | $29.24 M | -7.65% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.62 M | $29.89 M | 0.89% | 1.72% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 1.49 M | $27.44 M | -4.84% | 1.58% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.47 M | $27.08 M | 0.00% | 1.56% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.39 M | $25.61 M | 13.07% | 1.47% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.20 M | $22.21 M | 1,041.70% | 1.28% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 1.10 M | $20.32 M | 0.00% | 1.17% |
| NOVO HOLDINGS A/S | 10/24/2024 | 1.10 M | $20.32 M | 0.00% | 1.17% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 1.07 M | $19.70 M | 100.00% | 1.13% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 931,851 | $17.21 M | -25.25% | 0.99% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 912,605 | $16.86 M | -3.55% | 0.97% |
| BAMCO INC /NY/ | 11/14/2024 | 884,341 | $16.33 M | -9.70% | 0.94% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 812,310 | $15.00 M | 19.86% | 0.86% |
| COMERICA BANK | 11/14/2024 | 785,526 | $14.51 M | 14.40% | 0.83% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 770,691 | $14.23 M | 0.00% | 0.82% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 750,000 | $13.85 M | 0.00% | 0.80% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 749,000 | $13.83 M | -31.91% | 0.80% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 621,306 | $11.48 M | 10.75% | 0.66% |
| MORGAN STANLEY | 11/14/2024 | 615,528 | $11.37 M | 29.32% | 0.65% |
| WOODLINE PARTNERS LP | 11/14/2024 | 601,063 | $11.10 M | 6.96% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 569,814 | $10.52 M | 3.70% | 0.61% |
| JPMORGAN CHASE & CO | 11/08/2024 | 556,552 | $10.28 M | -4.00% | 0.59% |
| FMR LLC | 11/13/2024 | 465,456 | $8.60 M | -19.65% | 0.49% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 424,073 | $7.83 M | -39.06% | 0.45% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 406,159 | $7.50 M | -67.19% | 0.43% |
| M28 CAPITAL MANAGEMENT LP | 11/12/2024 | 385,680 | $7.12 M | 0.00% | 0.41% |
| INVESCO LTD. | 11/12/2024 | 352,622 | $6.51 M | 0.17% | 0.37% |
| GREAT LAKES ADVISORS, LLC | 11/04/2024 | 347,625 | $6.42 M | 100.00% | 0.37% |
| UBS GROUP AG | 11/14/2024 | 338,134 | $6.25 M | -16.67% | 0.36% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 325,000 | $6.00 M | -7.14% | 0.35% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 294,800 | $5.44 M | 17.46% | 0.31% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 291,106 | $5.38 M | 11.39% | 0.31% |
| WCM INVESTMENT MANAGEMENT, LLC | 11/04/2024 | 285,665 | $5.27 M | -2.47% | 0.30% |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 11/12/2024 | 244,420 | $4.52 M | 10.08% | 0.26% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 235,004 | $4.34 M | -39.27% | 0.25% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 231,792 | $4.28 M | 12.01% | 0.25% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 221,046 | $4.08 M | 8.30% | 0.23% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 197,096 | $3.64 M | 0.00% | 0.21% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 190,000 | $3.51 M | -24.11% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 184,233 | $3.40 M | -23.20% | 0.20% |
Rocket Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 231 institutional investors and hedge funds held shares of Rocket Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 17.69 M
WELLINGTON MANAGEMENT GROUP LLP: 11.24 M
BlackRock Funding, Inc. /DE: 6.37 M
VANGUARD GROUP INC: 5.54 M
WESTFIELD CAPITAL MANAGEMENT CO LP: 4.49 M
MAVERICK CAPITAL LTD: 4.12 M
98.29% of Rocket Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 235.94 M shares in the last 24 months. This purchase volume represents approximately $2.76 B in transactions.